(Image Credit - Sanja Gjenero)
The closing bell has rung and now it's time to take stock of the day's market action.
In today's session, market moves were relatively muted across our global marijuana stock universe. However, a few names posted noteworthy gains in today's trading.
In alphabetical order by symbol, 3 of the biggest marijuana stock gainers in trading on Thursday, May 18th, 2017 are as follows:
Cara Therapeutics Inc.
Shares of NASDAQ-Listed cannabinoid biotech company, Cara Therapeutics (NASDAQ:CARA) finished today's trading up 8.08%. Today's bullish action came without any recent news from the company. Be sure to check out Cara Therapeutics' marijuana stock profile linked above to view custom charts and news regarding the company.
Digipath Inc. (OTC:DIGP) closed today's trading session up 4.69% without any recent news from the company. Be sure to check out Digipath's marijuana stock profile linked above to view custom charts, news and more.
Shares of Neutra Corp. (OTC:NTRR) stood out in today's trading session, gaining 11.90% without any recent news. Be sure to check out Neutra's marijuana stock profile linked above to to view a custom chart and put today's move into perspective.
To find more about any of today's marijuana stock gainers, check out their profile in our cannabis-related stock database via the linked ticker symbols above.
Keep up with cannabis stock and industry updates from the Daily Marijuana Observer by following us on social media and by subscribing to our email newsletter below.
Now read: Today's Top Marijuana Stock Losers
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.